ArticleWorld journal of nuclear medicine2024

Fibroblast Activation Protein Inhibitor Theranostics: A Huge Opportunity with its Fair Share of Oncological Pitfalls.

Akram Al-IbraheemPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.